Mertz Leslie
IEEE Pulse. 2020 Sep-Oct;11(5):28-31. doi: 10.1109/MPULS.2020.3022203.
An at-home test for coronavirus disease 2019 (COVID-19) could be released commercially as early as August, according to Scanwell Health of Los Angeles. A combination of a finger-prick blood sample and a smart-phone app, the test is designed to detect the presence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19. The company hopes to receive Emergency Use Authorization from the U.S. Food and Drug Administration (FDA) by the end of summer, and make its first commercially available tests soon after.
据洛杉矶的Scanwell Health公司称，一种针对2019冠状病毒病（COVID-19）的家用检测产品最早可能在8月上市销售。该检测结合了手指采血样本和一款智能手机应用程序，旨在检测针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的抗体的存在，SARS-CoV-2正是引发COVID-19的病毒。该公司希望在夏末获得美国食品药品监督管理局（FDA）的紧急使用授权，并在之后不久推出首批可供商业销售的检测产品。
